These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 15719168)

  • 1. Heparan sulfate-protein interactions: therapeutic potential through structure-function insights.
    Coombe DR; Kett WC
    Cell Mol Life Sci; 2005 Feb; 62(4):410-24. PubMed ID: 15719168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.
    Powell AK; Yates EA; Fernig DG; Turnbull JE
    Glycobiology; 2004 Apr; 14(4):17R-30R. PubMed ID: 14718374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds.
    Leveugle B; Scanameo A; Ding W; Fillit H
    Neuroreport; 1994 Jun; 5(11):1389-92. PubMed ID: 7522615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin X binds to cell surface heparan sulfate proteoglycans.
    Nascimento FD; Rizzi CC; Nantes IL; Stefe I; Turk B; Carmona AK; Nader HB; Juliano L; Tersariol IL
    Arch Biochem Biophys; 2005 Apr; 436(2):323-32. PubMed ID: 15797245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of heparan sulfate interactions with Slit proteins.
    Zhang F; Ronca F; Linhardt RJ; Margolis RU
    Biochem Biophys Res Commun; 2004 Apr; 317(2):352-7. PubMed ID: 15063764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and heparan sulfate biosynthesis.
    Sugahara K; Kitagawa H
    IUBMB Life; 2002 Oct; 54(4):163-75. PubMed ID: 12512855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor.
    Foxall C; Holme KR; Liang W; Wei Z
    Anal Biochem; 1995 Nov; 231(2):366-73. PubMed ID: 8594987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of glycosaminoglycans and their interactions with proteins.
    Gandhi NS; Mancera RL
    Chem Biol Drug Des; 2008 Dec; 72(6):455-82. PubMed ID: 19090915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate-protein interactions--a concept for drug design?
    Lindahl U
    Thromb Haemost; 2007 Jul; 98(1):109-15. PubMed ID: 17598000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical interaction of the metallopeptidase PHEX with heparan sulfate proteoglycans.
    Barros NM; Nascimento FD; Oliveira V; Juliano MA; Juliano L; Loisel T; Nader HB; Boileau G; Tersariol IL; Carmona AK
    Int J Biochem Cell Biol; 2008; 40(12):2781-92. PubMed ID: 18585473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of dissociation constants for a heparin-binding domain of amyloid precursor protein and heparins or heparan sulfate by affinity capillary electrophoresis.
    McKeon J; Holland LA
    Electrophoresis; 2004 May; 25(9):1243-8. PubMed ID: 15174044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analysis of heparan sulphate and heparin oligosaccharides.
    Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
    Casu B; Naggi A; Torri G
    Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental roles of heparan sulfate proteoglycans: a comparative review in Drosophila, mouse and human.
    Princivalle M; de Agostini A
    Int J Dev Biol; 2002 May; 46(3):267-78. PubMed ID: 12068947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites.
    Mitsi M; Hong Z; Costello CE; Nugent MA
    Biochemistry; 2006 Aug; 45(34):10319-28. PubMed ID: 16922507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
    Graham LD; Whitelock JM; Underwood PA
    Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-synthetic heparin derivatives: chemical modifications of heparin beyond chain length, sulfate substitution pattern and N-sulfo/N-acetyl groups.
    Fernández C; Hattan CM; Kerns RJ
    Carbohydr Res; 2006 Jul; 341(10):1253-65. PubMed ID: 16712822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between heparan sulfate and proteins-design and functional implications.
    Lindahl U; Li JP
    Int Rev Cell Mol Biol; 2009; 276():105-59. PubMed ID: 19584012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of heparan sulfate biosynthetic enzyme machinery and characterization of heparan sulfate structure in Nematostella vectensis.
    Feta A; Do AT; Rentzsch F; Technau U; Kusche-Gullberg M
    Biochem J; 2009 May; 419(3):585-93. PubMed ID: 19170656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.
    Hecht ML; Rosental B; Horlacher T; Hershkovitz O; De Paz JL; Noti C; Schauer S; Porgador A; Seeberger PH
    J Proteome Res; 2009 Feb; 8(2):712-20. PubMed ID: 19196184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.